Article
Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.
Cancer immunology, immunotherapy : CII - 1 Mar 2022
Kobayashi Mizuki, Fujiyama Nobuhiro, Tanegashima Tokiyoshi, Narita Shintaro, Yamamoto Yoshiaki, Fujimoto Naohiro, Ueda Shohei, Takeuchi Ario, Numakura Kazuyuki, Habuchi Tomonori, Matsuyama Hideyasu, Eto Masatoshi, Shiota Masaki
Abstract excerpt
The intravesical administration of bacillus Calmette-Guérin (BCG) is widely used to control the intravesical recurrence of non-muscle-invasive bladder cancer (NMIBC). This study aimed to reveal the effects of zygosity on human leukocyte antigen (HLA) genes and individual HLA genotypes on intravesical recurrence after intravesical BCG therapy for NMIBC. This study included Japanese patients who had received...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
